Send me a link:

*Text messaging rates may apply.

 Dow Down 0.33% Nasdaq Up 0.21%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
322.59 Up 18.08(5.94%) 12:23PM EDT - Nasdaq Real Time Price
Prev Close:304.51
Open:328.55
Bid:323.24 x 100
Ask:323.46 x 100
1y Target Est:345.83
Beta:0.86
Next Earnings Date: 5-Aug-14REGN Earnings announcement
Day's Range:321.60 - 336.94
52wk Range:227.64 - 352.49
Volume:1,436,844
Avg Vol (3m):805,783
Market Cap:31.84B
P/E (ttm):92.49
EPS (ttm):3.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for REGN

Comparison

Symbol% ChgMkt Cap
REGNUp 5.94%31.84B
AMGNUp 5.26%98.26B
NVSDown 0.02%213.97B
RHHBYUp 0.30%249.10B

Key Statistics

Forward P/E (1 yr):28.02
P/S (ttm):13.12
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :9.91
Quarterly EPS Est (Jun-14) :2.28
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.50

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback